PATENT CLAIM ANALYSIS

Application Number: 16167073
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "024000"]

Abstract:
A dry formulation may include one or more active agents including one or more anti-infective agents such as an anti-bacterial agent, anti-fungal agent, or other anti-active agent. The dry formulation may be prepared for administration by mixing the dry formulation with a diluent. In one example, the diluent is a hydrocortisone and acetic acid solution or a sodium chloride solution. The combined preparation may be administered to the ear or skin to treat or prevent an infection.

Claim (Index 20):
The method of  claim 19 , wherein preparing the dry formulation comprises mixing a therapeutically effective amount of the mupirocin, a therapeutically effective amount of the clindamycin hydrochloride, and a therapeutically effective amount of the clotrimazole to form a homogenous dry formulation for mixing with the diluent.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 97.0
- Lexical Diversity: 1.61538
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15602395', '14975172', '14975279', '15597936', '15668449']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7574057504929479
- 35 USC 102 Novelty (BERT): 0.5834791992271849
- Combined Prediction Score: 0.7400130953663716
- Mean Citation Score: 322.4600660000001
- Max Citation Score: 483.29074
- Similarity Product: 395.6868152406002

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test